KELLY NUCKLEY: Open Payments
NPI 1194365114 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 19 payments from 9 companies in 2025. Trend: 2023 $858 · 2024 $1,073 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $94 |
| Janssen Pharmaceuticals, Inc | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Alkermes, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, SPRAVATO, REXULTI, UZEDY, COBENFY, ARISTADA, FANAPT, INVEGA.
Industry payments across LA — which companies pay providers there.
